YTE reported $172.83M in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -33.57M 79M
Agenus AGEN:US $ -49.24M 1.37M
Agios Pharmaceuticals AGIO:US $ -91.81M 2.97M
Alnylam Pharmaceuticals ALNY:US $ -274.67M 35.32M
Biogen BIIB:US $ 874.8M 28.6M
Biomarin Pharmaceutical BMRN:US $ 34.85M 8.66M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Chemocentryx CCXI:US $ -31.65M 6.96M
Clovis Oncology CLVS:US $ -71.37M 11.08M
Cti Biopharma CTIC:US $ -22.65M 14.52M
Exelixis EXEL:US $ 88.51M 3.28M
Idera Pharmaceuticals IDRA:US $ -5.31M 1.13M
Intercept Pharmaceuticals ICPT:US $ -20.32M 3.04M
IONIS PHARMACEUT IONS:US $ -103M 39M
Macrogenics MGNX:US $ -41.3M 25.14M
Mirati Therapeutics MRTX:US $ -176.44M 11.94M
Nektar Therapeutics NKTR:US $ -158.97M 68.7M
Neurocrine Biosciences NBIX:US $ -23.3M 44.7M
Newlink Genetics NLNK:US $ -7.84M 0.12M
Novartis NOVN:VX SF 4129M 217M
Novartis NVS:US $ 4129M 217M
Ptc Therapeutics PTCT:US $ -148.7M 26.8M
Sarepta Therapeutics SRPT:US $ -228.09M 123.95M
Ultragenyx Pharmaceutical RARE:US $ -157.86M 6.1M